Navigation Links
New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma
Date:5/30/2008

search, the largest international academic institute dedicated to understanding and controlling cancer. MAGE-A3 ASCI is an investigational compound and it is not approved for use in any indication in any country at this time.

About melanoma

Melanoma is a type of cancer which develops when melanocytes (pigment cells in the skin) become malignant and start to grow and divide at an abnormally quick pace, spreading into the surrounding surface layers of skin. According to the World Health Organization (WHO), two to three million non-melanoma skin cancers and 132,000 melanoma skin cancers occur globally each year.(5)

About non-small cell lung cancer

According to the Global Lung Cancer Coalition, more than 1.2 million new cases of lung cancer are diagnosed each year worldwide, and approximately 1.1 million deaths occur annually around the world.(6)

About GlaxoSmithKline and GlaxoSmithKline Biologicals

GSK Biologicals (GSK Bio), one of the world's leading vaccine manufacturers, is headquartered in Rixensart, Belgium, where the majority of GlaxoSmithKline's activities in the field of vaccine research, development and production are conducted. GSK Bio employs more than 1,500 scientists, who are devoted to discovering new vaccines and developing more cost-effective and convenient combination products to prevent infections that cause serious medical problems worldwide. GSK Bio is also developing innovative immunotherapy compounds to treat cancer patients.

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information please visit http://www.gsk.com.

Cautionary statement regarding forward-looking statements

Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 199
'/>"/>

SOURCE GlaxoSmithKline (GSK)
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Presentation of Data on Progens Cancer Epigenetic Targets Platform
2. Genmab Announces Updates on Phase III Cancer Studies
3. Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium
4. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
5. BiPar Sciences Expands Clinical Development of BSI-201, A Novel PARP Inhibitor, With Phase 2 Trial in Uterine Cancer
6. Prostate Cancer Treatment Offers Results Without Side Effects
7. TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)
8. First Patient Enrolled in Global Phase III Study of Bevacizumab and Trastuzumab in Early Breast Cancer
9. Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy
10. Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center
11. Ovarian Cancer Vaccine Clinical Trial Begins at Cancer Treatment Centers of America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... BEDFORD, Mass. , Sept. 1, 2015 ... investigating whether certain officers and directors of ... Act of 1934.  ConforMIS is a medical technology company ... manufacture, and sell joint replacement implants that are individually ... View this press release on the law ...
(Date:9/1/2015)... Calif. , Sept. 1, 2015  Amgen ... collaboration with Novartis in the areas of Alzheimer,s ... entry into Alzheimer,s disease by teaming up with ... disease program directed at genetically predisposed individuals at ... Amgen to focus on the commercialization of its ...
(Date:9/1/2015)... -- AccuTec Blades, Inc. today announced the acquisition of Edgewell ... in May 2015 its intent to discontinue its industrial ... and Obregon, Mexico . Today,s announcement ... Rick Gagliano , the newly-appointed President and ... name, AccuTec Blades, reflects the precision and accuracy of ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of ConforMIS, Inc. (CFMS) on Behalf of Shareholders 2Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 2Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 3Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 4Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 5Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 6Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 7Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 8Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 9AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2
... (NYSE: SYK ) announced today that its Board of Directors has ... July 30, 2010 to shareholders of record at the close of business ... , , ... is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing ...
... ,, MINNEAPOLIS , June 21 HeartSine Technologies Ltd. recently ... of the most exciting companies with operations in the U.S. and Ireland ... Other companies on this year,s ... biggest-selling newspaper serving Irish America , included Aon Corporation, BNY Mellon, Bimeda, ...
Cached Medicine Technology:HeartSine Technologies Recognized as an Index 30 Company at New York-New Belfast Conference 2
(Date:9/1/2015)... ... September 01, 2015 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... Lymphoma awareness initiative, the nation’s premier and most high-profile lymphoma awareness campaign. Since ...
(Date:9/1/2015)... ... September 01, 2015 , ... From Aug. 17-21, Calvary Hospital ... from ages 6-18. Calvary’s Camp Compass® has taken place at Kingsborough Community College in ... counselors, some of whom work for Calvary, and two junior counselors who were campers ...
(Date:9/1/2015)... ... September 01, 2015 , ... Georgia State University ... across the country in stemming sexual assaults on their campuses. , The free, ... consortium of sexual assault researchers and student affairs professionals responding to calls by ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... care delivery options, Blue Cross and Blue Shield of Minnesota (Blue Cross) has ... 2016. , Based in San Francisco, Doctor On Demand provides immediate access ...
(Date:9/1/2015)... ... September 01, 2015 , ... Virginia ... Machine,” is still strongly maintaining her firm’s success in the hair care and ... her upcoming city-to-city tour, Ellis will be providing “Look and learn” live demonstrations, ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 2Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Georgia State, Partners Introduce Climate Survey to Aid in Preventing Campus Sexual Assaults 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2
... media and others interested in the chemical sciences are ... American Chemical Society (ACS) Webinars, focusing on how to ... programs. Scheduled for Thursday, Sept. 16, from 2 ... feature Josephine Yuen, Ph.D., NSF Program Director, speaking on ...
... for Personalized Medicine , Author: Shara Yurkiewicz, Summary: Ten ... the human genome, major changes have made their way ... Title: Personalized Medicine,s Ragged Edge, Author: Leonard M. Fleck, ... spin. But little attention has been given to some ...
... , THURSDAY, Sept. 9 (HealthDay News) -- A ... heads-up about the kinds of medical problems that may face ... to use a computational method to create a score based ... rate during the first three hours after birth. In a ...
... living in California, Laotian/Hmong-Americans have the lowest survival rates ... new study by researchers with the UC Davis School ... largest population-based examination of liver cancer rates among Asian-Americans, ... to detect and treat the disease earlier among Laotian/Hmong-Americans, ...
... Academy of Orthopaedic Surgeons (AAOS) recently approved and released ... periprosthetic joint infections of the hip and knee. Clinical ... ensure that patients receive high quality care. A ... organisms enter the wound during or at any point ...
... By Steven Reinberg HealthDay Reporter , ... their ability to lower cholesterol and prevent heart attacks ... rheumatoid arthritis, Israeli researchers report. "We ... were less likely to develop rheumatoid arthritis over a ...
Cached Medicine News:Health News:American Chemical Society Webinar focuses on NSF's small business funding programs 2Health News:The Hastings Center Report table of contents for September-October 2010 2Health News:The Hastings Center Report table of contents for September-October 2010 3Health News:New Tool Aims to Predict Problems in Preemies 2Health News:UC Davis study finds low liver cancer survival rates among Laotian/Hmong-Americans 2Health News:UC Davis study finds low liver cancer survival rates among Laotian/Hmong-Americans 3Health News:Joint replacement: Does this look infected to you? 2Health News:Joint replacement: Does this look infected to you? 3Health News:Statins May Guard Against Rheumatoid Arthritis 2Health News:Statins May Guard Against Rheumatoid Arthritis 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: